Scheinberg DA. Immune reconstitution and remission in CML. Blood. 2017;129(9):1064-1065.

In the conflict-of-interest disclosure on page 1065 in the 2 March 2017 issue, the disclosures that the author serves as an advisor to and owns equity in Sellas Life Sciences and Eureka Therapeutics were missing. Furthermore, Memorial Sloan Kettering Cancer Center has filed patent applications for antibodies on which the author is an inventor. The errors have been corrected in the online version of the article.